Page last updated: 2024-07-31 20:32:58

phillygenin

Description

phillygenin: cytoprotective lignan from Forsythia suspensa; structure in first source [MeSH]

Cross-References

ID SourceID
PubMed CID3083590
CHEMBL ID2260010
SCHEMBL ID10052265
MeSH IDM0537666

Synonyms (33)

Synonym
phenol, 4-(4-(3,4-dimethoxyphenyl)tetrahydro-1h,3h-furo(3,4-c)furan-1-yl)-2-methoxy-, (1s-(1alpha,3aalpha,4beta,6aalpha))-
unii-886ial08gn
phillygenol
epipinoresinol methyl ether
phillygenin
487-39-8
886ial08gn ,
ACON1_001142
sylvatesmin
MEGXP0_000876
NCGC00169636-01
BRD-K69431605-001-01-7
4-[(3s,3ar,6r,6ar)-6-(3,4-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenol
S9187
(+)-monomethylpinoresinol
(+)-phillygenin
phillyrin aglycone
phenol, 4-((1s,3ar,4r,6ar)-4-(3,4-dimethoxyphenyl)tetrahydro-1h,3h-furo(3,4-c)furan-1-yl)-2-methoxy-
CHEMBL2260010
SCHEMBL10052265
AC-34423
Q-100547
DTXSID80197588
CS-5705
HY-N0483
AKOS030524964
4-((1s,3ar,4r,6ar)-4-(3,4-dimethoxyphenyl)tetrahydro-1h,3h-furo[3,4-c]furan-1-yl)-2-methoxyphenol
mfcd01075148
forsythigenol
CCG-268325
Q27269895
(+)-sylvatesmin
AS-56623

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1371010Anti-inflammatory activity in human neutrophils assessed as inhibition of fMLP/CB-induced superoxide anion generation by measuring superoxide dismutase SOD-inhibitable ferricytochrome c reduction incubated for 5 mins before fMLP/CB stimulation for 3 mins 2017Journal of natural products, 04-28, Volume: 80, Issue:4
ISSN: 1520-6025
Chemical Constituents and Anti-inflammatory Principles from the Fruits of Forsythia suspensa.
AID1371011Anti-inflammatory activity in human neutrophils assessed as inhibition of fMLP/CB-induced elastase release pre-incubated for 5 mins before fMLP/CB stimulation using MeO-Suc-Ala-Ala-Pro-Val-pnitroanilide as substrate2017Journal of natural products, 04-28, Volume: 80, Issue:4
ISSN: 1520-6025
Chemical Constituents and Anti-inflammatory Principles from the Fruits of Forsythia suspensa.
AID1371012Anti-inflammatory activity in human neutrophils assessed as inhibition of fMLP/CB-induced superoxide anion generation by measuring superoxide dismutase SOD-inhibitable ferricytochrome c reduction at 10 ug/ml incubated for 5 mins before fMLP/CB stimulation2017Journal of natural products, 04-28, Volume: 80, Issue:4
ISSN: 1520-6025
Chemical Constituents and Anti-inflammatory Principles from the Fruits of Forsythia suspensa.

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (9.52)29.6817
2010's7 (33.33)24.3611
2020's12 (57.14)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.55%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (95.45%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
ursolic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
geroprotector;
plant metabolite
201720177.0low000010
pinoresinolpinoresinolhypoglycemic agent;
phytoestrogen;
plant metabolite
201720177.0medium000010
matairesinolgamma-lactone;
lignan;
polyphenol
angiogenesis inhibitor;
anti-asthmatic agent;
phytoestrogen;
plant metabolite
201720177.0low000010
oleanolic acid 3-acetate201720177.0low000010
sorafenib(trifluoromethyl)benzenes;
aromatic ether;
monochlorobenzenes;
phenylureas;
pyridinecarboxamide
angiogenesis inhibitor;
anticoronaviral agent;
antineoplastic agent;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
ferroptosis inducer;
tyrosine kinase inhibitor
201720177.0low000010
epipinoresinolpinoresinolmarine metabolite;
plant metabolite
201720177.0medium000010
forsythiasidehydroxycinnamic acid201720177.0low000010
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
molsidomineethyl ester;
morpholines;
oxadiazole;
zwitterion
antioxidant;
apoptosis inhibitor;
cardioprotective agent;
nitric oxide donor;
vasodilator agent
2009200915.0low000100
linsidominemorpholines2009200915.0low000100
carbon tetrachloridechlorocarbon;
chloromethanes
hepatotoxic agent;
refrigerant
202220222.0low000001
diquatorganic cationdefoliant;
herbicide
2010201014.0low000100
furaldehydealdehyde;
furans
Maillard reaction product;
metabolite
2010201014.0low000100
diethylhexyl phthalatediester;
phthalate ester
androstane receptor agonist;
apoptosis inhibitor;
plasticiser
2010201014.0low000100
podophyllotoxinfuronaphthodioxole;
lignan;
organic heterotetracyclic compound
antimitotic;
antineoplastic agent;
keratolytic drug;
microtubule-destabilising agent;
plant metabolite;
tubulin modulator
202020204.0low000010
glucose, (beta-d)-isomerD-glucopyranoseepitope;
mouse metabolite
2009201711.0low000110
masoprocolnordihydroguaiaretic acidantineoplastic agent;
hypoglycemic agent;
lipoxygenase inhibitor;
metabolite
202020204.0low000010
diphyllinlignan202020204.0low000010
peroxynitrous acidnitrogen oxoacid2009200915.0low000100
5-hydroxymethylfurfuralarenecarbaldehyde;
furans;
primary alcohol
indicator;
Maillard reaction product
2010201014.0low000100
lignans200920226.9high000467
gamma-sitosterol3beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
phytosterols
marine metabolite;
plant metabolite
2010201014.0low000100
terameprocollignan202020204.0low000010
glycosides2009201014.5low000200
1,1-diphenyl-2-picrylhydrazyl2010201014.0low000100
8-hydroxypinoresinollignan2009200915.0medium000100
cytellin2010201014.0low000100
dinoprostoneprostaglandins Ehuman metabolite;
mouse metabolite;
oxytocic
202120213.0low000001
stigmasterol3beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
phytosterols;
stigmastane sterol
plant metabolite2010201014.0low000100
forsythiasidehydroxycinnamic acid2009201014.5low000200
suspensaside201720177.0medium000010
acteosidecatechols;
cinnamate ester;
disaccharide derivative;
glycoside;
polyphenol
anti-inflammatory agent;
antibacterial agent;
antileishmanial agent;
neuroprotective agent;
plant metabolite
201720177.0low000010
bicyclol202020204.0low000010
phillyrin2009200915.0low000100
ascorbic acidascorbic acid;
vitamin C
coenzyme;
cofactor;
flour treatment agent;
food antioxidant;
food colour retention agent;
geroprotector;
plant metabolite;
skin lightening agent
2010201014.0low000100
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Ache0202220222.0low000001
Acute Lung Injury0202120213.0low000001
Anasarca0202220222.0low000001
Cancer of Esophagus0201920195.0low000010
Cirrhosis, Liver0202020232.3low000012
Colitis0202220231.5low000002
Colitis Gravis0202320231.0low000001
Colitis, Ulcerative0202320231.0low000001
Coronavirus Infections0202220222.0low000001
Disease Models, Animal0202220222.0low000001
Edema0202220222.0low000001
Esophageal Neoplasms0201920195.0low000010
Fatty Liver, Nonalcoholic0202220222.0low000001
Hepatitis0202020204.0low000010
Infections, Coronavirus0202220222.0low000001
Inflammation0202120232.2medium000005
Innate Inflammatory Response0202120232.2medium000005
Liver Cirrhosis0202020232.3low000012
Lung Injury, Acute0202120213.0low000001
Metastase0202120213.0low000001
Neoplasm Metastasis0202120213.0low000001
Non-alcoholic Fatty Liver Disease0202220222.0low000001
Osteogenic Sarcoma0202120213.0low000001
Osteosarcoma0202120213.0low000001
Pain0202220222.0low000001
Poultry Diseases0202220222.0low000001

Pharmacokinetics (1)

ArticleYear
Determination of phillygenin in rat plasma by high-performance liquid chromatography and its application to pharmacokinetic studies.
European journal of drug metabolism and pharmacokinetics, , Volume: 38, Issue:3
2013